Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,694 | -43,857 | -338,790 | -275,610 | -235,503 |
| Depreciation Amortization | N/A | N/A | -1,354 | 964 | 964 |
| Accounts receivable | N/A | N/A | 375 | 212 | -1,271 |
| Accounts payable and accrued liabilities | 2,335 | 2,210 | 218 | 1,001 | 2,045 |
| Other Working Capital | -25,683 | 3,473 | -5,206 | -3,343 | 4,608 |
| Other Operating Activity | 15,252 | 9,632 | 244,847 | 207,902 | 194,880 |
| Operating Cash Flow | $-90,790 | $-28,542 | $-99,910 | $-68,874 | $-34,277 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -225,481 | -104,963 | -126,903 | -91,631 | 21,000 |
| PPE Investments | N/A | N/A | 475 | 475 | 475 |
| Net Acquisitions | N/A | N/A | 3,035 | 3,035 | 3,035 |
| Other Investing Activity | 0 | 0 | 15,000 | 15,000 | 0 |
| Investing Cash Flow | $-225,481 | $-104,963 | $-108,393 | $-73,121 | $24,510 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -16 | -16 | -16 |
| Common Stock Issued | 4,885 | 4,390 | 84,960 | 123 | 18 |
| Other Financing Activity | 167,640 | 167,775 | 276,133 | 197,364 | 210,000 |
| Financing Cash Flow | $172,525 | $172,165 | $361,077 | $197,471 | $210,002 |
| Exchange Rate Effect | -4 | -4 | 25 | 7 | 24 |
| Beginning Cash Position | 189,215 | 189,215 | 36,416 | 36,416 | 36,416 |
| End Cash Position | 45,465 | 227,871 | 189,215 | 91,899 | 236,675 |
| Net Cash Flow | $-143,750 | $38,656 | $152,799 | $55,483 | $200,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,790 | -28,542 | -99,910 | -68,874 | -34,277 |
| Free Cash Flow | -90,790 | -28,542 | -99,910 | -68,874 | -34,277 |